BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10851527)

  • 1. Immunological directives for biotherapy improvement in the treatment of colorectal cancer.
    Pellegrini P; Berghella AM; Del Beato T; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Apr; 11(2):113-8. PubMed ID: 10851527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer.
    Contasta I; Pellegrini P; Berghella AM; Del Beato T; Canossi A; Di Rocco M; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Dec; 11(6):373-83. PubMed ID: 10851498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the soluble CD30 serum level in colorectal cancer: a possible marker for a patient subset which could benefit from IL-2 biotherapy.
    Dle Beato T; Berghella AM; Pellegrini P; Domenico A; Casciani CU
    Cancer Biother Radiopharm; 1997 Oct; 12(5):297-304. PubMed ID: 10851480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of immunological evaluation in colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Maccarone D; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Dec; 11(6):355-61. PubMed ID: 10851496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer.
    Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Cencioni S; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Aug; 12(4):257-64. PubMed ID: 10851473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and cell cycle analysis of human peripheral blood mononuclear cells activated with interleukin-2 and/or OKT3.
    Platts KE; Lawry J; Hancock BW; Rees RC
    Exp Cell Res; 1993 Sep; 208(1):154-60. PubMed ID: 8359215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.
    Wasik MA; Morimoto C
    J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional modulation of interleukin-2-activated peripheral blood mononuclear cells by anti-CD3 and anti-CD28 antibody.
    Yoshino I; Yano T; Miyamoto M; Sugimachi K; Kimura G; Nomoto K
    Lymphokine Cytokine Res; 1993 Aug; 12(4):191-6. PubMed ID: 8218591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma.
    Manchanda P; Sharma SC; Das SN
    Oral Dis; 2006 Sep; 12(5):455-62. PubMed ID: 16910915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations.
    Berghella AM; Pellegrini P; Piancatelli D; Maccarone D; Del Beato T; Giubilei D; Pomidori A; Adorno D; Casciani CU
    Cancer Immunol Immunother; 1994 Mar; 38(3):160-6. PubMed ID: 7907273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease stage prognostic indices in the early clinical screening of colorectal cancer patients.
    Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Casciani CU; Adorno D
    Cancer Biother Radiopharm; 1998 Apr; 13(2):89-98. PubMed ID: 10850345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
    Suda T; Murray R; Guidos C; Zlotnik A
    J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of lymphocyte subsets before and after chemotherapy in colorectal carcinoma patients].
    Zhang GQ; Zhao H; Wen XY; Li JY; Wu LL; Jiao SC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):155-60. PubMed ID: 23643003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.